These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36606199)

  • 1. Distinct tumor microenvironment landscapes in gastric cancer classified by cuproptosis-related lncRNAs.
    Huang J; Chen M; Pei W; Xu Z; Ning J; Chen C
    J Cancer; 2022; 13(15):3687-3700. PubMed ID: 36606199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Cuproptosis-Related Subtypes, Establishment of a Prognostic Signature and Characterization of the Tumor Microenvironment in Gastric Cancer.
    Li J; Kong C; Song W; Fu T
    Int J Gen Med; 2023; 16():1631-1652. PubMed ID: 37168531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuproptosis-Mediated Patterns Characterized by Distinct Tumor Microenvironment and Predicted the Immunotherapy Response for Gastric Cancer.
    Wang XX; Deng SZ; Wu LH; Liu QQ; Zheng G; Du K; Dou QY; Zheng J; Zhang HM
    ACS Omega; 2023 Mar; 8(12):10851-10862. PubMed ID: 37008098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma.
    Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; Abrão FC; Puthamohan VM; Liu L; Jiang T
    Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer.
    Li W; Zhang X; Chen Y; Pang D
    Front Oncol; 2022; 12():966511. PubMed ID: 36212436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer.
    Zhu Z; Zhao Q; Li S; Weng J; Guo T; Zhu C; Xu Y
    Front Genet; 2022; 13():984743. PubMed ID: 36467996
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
    World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients.
    Jiang ZR; Yang LH; Jin LZ; Yi LM; Bing PP; Zhou J; Yang JS
    Front Oncol; 2022; 12():988680. PubMed ID: 36203428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer.
    Wang Q; Xu Y
    Front Pharmacol; 2022; 13():1065701. PubMed ID: 36532719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of cuproptosis-related genes in prognosis, tumor microenvironment infiltration, and immunotherapy response in gastric cancer.
    Nie H; Wang H; Zhang M; Ning Y; Chen X; Zhang Z; Hu X; Zhao Q; Chen P; Fang J; Wang F
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5453-5468. PubMed ID: 36462036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk of cuproptosis-related subtypes, establishment of a prognostic signature, and immune infiltration characteristics in gastric cancer.
    Wang Y; Guo F; Song W; Guo W; Shao J; Liu Y
    Heliyon; 2024 Jan; 10(2):e24411. PubMed ID: 38298669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
    Front Genet; 2022; 13():947551. PubMed ID: 35938003
    [No Abstract]   [Full Text] [Related]  

  • 14. LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer.
    Qi S; Feng H; Li X
    Front Genet; 2023; 14():1120089. PubMed ID: 37124623
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis.
    Li D; Wu X; Song W; Cheng C; Hao L; Zhang W
    Ann Transl Med; 2022 Nov; 10(22):1235. PubMed ID: 36544675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer.
    Liu X; Zhou L; Gao M; Dong S; Hu Y; Hu C
    Front Genet; 2022; 13():989646. PubMed ID: 36204323
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer.
    Hou D; Tan JN; Zhou SN; Yang X; Zhang ZH; Zhong GY; Zhong L; Yang B; Han FH
    Front Genet; 2022; 13():969845. PubMed ID: 36105091
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer.
    Feng A; He L; Chen T; Xu M
    Front Oncol; 2022; 12():957966. PubMed ID: 36106123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
    Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
    Front Immunol; 2022; 13():916800. PubMed ID: 35860239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.
    Li P; Li J; Wen F; Cao Y; Luo Z; Zuo J; Wu F; Li Z; Li W; Wang F
    Front Oncol; 2022; 12():966920. PubMed ID: 36276132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.